“Expanded Access” refers to the use of an investigational product outside of a clinical trial for potential treatment of a serious or life-threatening condition. Consistent with our commitment to bringing safe and effective therapies to patients, we are focused on enrolling and conducting the clinical trials necessary to gain regulatory approvals to make our investigational products available to patients as quickly and safely as possible. Currently, participation in one of our clinical trials is the only way to access our investigational products. We encourage patients interested in our investigational products to learn more about our ongoing studies by visiting www.clinicaltrials.gov.
Treating physicians may request information about our Expanded Access policy by contacting clinicaltrials@lbpharma.us. LB Pharmaceuticals will respond to inquiries within 5 business days of receipt.
LB Pharmaceuticals reserves the right to review and update this Expanded Access policy at any time to ensure conformity with applicable laws and regulations.
